We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · July 16, 2020

Superpotent Topical Corticosteroid Therapy in Bullous Pemphigoid

The British Journal of Dermatology

 

Additional Info

The British Journal of Dermatology
Feasibility and Healthcare Costs of Superpotent Topical Corticosteroid Therapy in Bullous Pemphigoid: A Prospective, Observational Study in an Academic Centre in France
Br J Dermatol 2020 Apr 22;[EPub Ahead of Print], A Clapé, C Muller, J Plée, M Viguier, C Vanhaecke, P Bernard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading